General Information of Drug Off-Target (DOT) (ID: OTQOYX6U)

DOT Name Speedy protein E1 (SPDYE1)
Synonyms Williams-Beuren syndrome chromosomal region 19 protein
Gene Name SPDYE1
UniProt ID
SPDE1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF11357
Sequence
MQKHYTVAWFLYSAPGVDPSPPCRSLGWKRKREWSDESEEEPEKELAPEPEETWVVETLC
GLKMKLKQQRVSPILLEHHKDFNSQLAPGVDPSPPHRSFCWKRKMEWWDKSEESEEEPRK
VLAPEPEEIWVAEMLCGLKMKLKRRRVSLVLPEHHEAFNRLLEDPVIKRFLAWDKDLRVS
DKYLLAMVIAYFSRAGFPSWQYQRLHFFLALYLANDMEEDDEDSKQNIFHFLYGKNRSRI
PLLRKRRFQLYRSMNPRARKNRSHIPLVRKRRFQLRRCMNPRARKNRSQIVLFQKRRFHF
FCSMSCRAWVSPEELEEIQAYDPEHWVWARDRARLS
Tissue Specificity Predominantly expressed in testis and heart.
KEGG Pathway
Oocyte meiosis (hsa04114 )
Progesterone-mediated oocyte maturation (hsa04914 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
4 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Zoledronate DMIXC7G Approved Zoledronate increases the expression of Speedy protein E1 (SPDYE1). [1]
Formaldehyde DM7Q6M0 Investigative Formaldehyde increases the expression of Speedy protein E1 (SPDYE1). [2]
Milchsaure DM462BT Investigative Milchsaure increases the expression of Speedy protein E1 (SPDYE1). [3]
KOJIC ACID DMP84CS Investigative KOJIC ACID increases the expression of Speedy protein E1 (SPDYE1). [4]
------------------------------------------------------------------------------------

References

1 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
2 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
3 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
4 Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull. 2006 Apr;29(4):655-69.